Asia-Pacific Digital PCR (dPCR) and Real-Time PCR (qPCR) Market

Asia-Pacific Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size, Share & Trends Analysis Report, By Technology (Quantitative PCR and Digital PCR), By Product (Reagents and Consumables, Instruments, and Software), By Application (Research Application, Clinical Application, and Forensic Application) and Forecast, 2019-2025
    Update Available - Forecast 2024-2030   

Published: Jul 2022 | Report Code: OMR2021179 | Category : Biotechnology | Delivery Format: /

Asia-Pacific digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow at a CAGR of 9.1% during the forecast period. Asia-Pacific market has been witnessing considerable growth owing to the rise in the incidence of infectious diseases and genetic disorders such as cancer, HIV and hepatitis. Due to the prevalence of various chronic diseases such as CVD and cancer in the region the demand for dPCR and qPCR instruments is increasing at consistent basis. 

Additionally, increasing advancement in PCR technique and increasing research activities that use the PCR supplement the growth of the market. However, technical shortcomings in the dPCR and qPCR along with the high price of advanced PCR devices are hampering the growth of the market during the forecast period. Thus, the market for dPCR and qPCR is rapidly growing in the region as the dPCR and qPCR are used in the diagnosis of the infectious diseases. Additionally, adoption in these Asian countries will reduce the economic burden of cancer on the respective governments by the timely and efficient diagnosis of diseases. 

The market growth in the region is attributed by the presence of some crucial players, such as Abbott Laboratories, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Takara Bio Inc. and many others. These key companies are actively adopting various strategies such as new product launches and approvals, merger and acquisition, partnerships and collaborations, and many others in order to thrive in a competitive environment. For instance, in January 2020, Takara Bio Inc. launched a new facility for research and manufacturing of regenerative medicine as the Center for Gene and Cell Processing II in Kusatsu, Shiga. Owing to an increasingly global presence, the company was facing insufficient capacity for manufacturing which led to this expansion. 

 Research Methodology

The market study of the Asia-Pacific dPCR and qPCR market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers. It will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

  1. Asia-Pacific dPCR and qPCR Market Research and Analysis, By Technology
  2. Asia-Pacific dPCR and qPCR Market Research and Analysis, By Product
  3. Asia-Pacific dPCR and qPCR Market Research and Analysis, By Application

The Report covers:

  • Comprehensive research methodology of the Asia-Pacific dPCR and qPCR market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Asia-Pacific DPCR and qPCR market.
  • Insights about market determinants which are stimulating the Asia-Pacific dPCR and qPCR market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Country

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis 

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. Overview

3.3.2. Financial Analysis

3.3.3. SWOT Analysis

3.3.4. Recent Developments

4. Market Determinants 

4.1. Motivators

4.2. Restraints

4.3. Opportunities 

5. Market Segmentation

5.1. Asia-Pacific dPCR and qPCR Market by Technology 

5.1.1. Quantitative PCR (qPCR)

5.1.2. Digital PCR (dPCR)

5.2. Asia-Pacific dPCR and qPCR Market by Product

5.2.1. Reagents and Consumables

5.2.2. Instruments

5.2.3. Software

5.3. Asia-Pacific dPCR and qPCR Market by Application

5.3.1. Research Application

5.3.2. Clinical Application

5.3.3. Forensic Application

6. Regional Analysis

6.1. China

6.2. India

6.3. Japan

6.4. Rest of Asia-Pacific

7. Company Profiles

7.1. Abbott Laboratories, Inc.

7.2. Agilent Technologies, Inc.

7.3. Becton, Dickinson and Co.

7.4. BioMérieux S.A.

7.5. Bio-Rad Laboratories, Inc.

7.6. Danaher Corp.

7.7. Eppendorf AG

7.8. JN Medsys

7.9. Merck KGaA

7.10. Takara Bio Inc. 

7.11. Thermo Fisher Scientific Inc.

1. ASIA-PACIFIC DPCR AND QPCR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

2. ASIA-PACIFIC DPCR AND QPCR MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION) 

3. ASIA-PACIFIC DPCR AND QPCR MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION) 

4. ASIA-PACIFIC DPCR AND QPCR MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION) 

1. ASIA-PACIFIC DPCR AND QPCR MARKET SHARE BY COUNTRY, 2018 VS 2025 (%)

2. ASIA-PACIFIC DPCR AND QPCR MARKET SHARE BY TECHNOLOGY, 2018 VS 2025 (%)

3. ASIA-PACIFIC DPCR AND QPCR MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)

4. ASIA-PACIFIC DPCR AND QPCR MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)

5. CHINA DPCR AND QPCR MARKET SIZE, 2018-2025 ($ MILLION)

6. INDIA DPCR AND QPCR MARKET SIZE, 2018-2025 ($ MILLION)

7. JAPAN DPCR AND QPCR MARKET SIZE, 2018-2025 ($ MILLION)

8. REST OF ASIA-PACIFIC DPCR AND QPCR MARKET SIZE, 2018-2025 ($ MILLION)